4:30 PM
 | 
Aug 19, 2013
 |  BC Extra  |  Company News

Velocity, Remeditex partner to evaluate assets

Velocity Pharmaceutical Development LLC (South San Francisco, Calif.) and life science VC firm Remeditex Ventures partnered to jointly evaluate late-stage preclinical and clinical-stage assets from pharma, biotech and academia. Velocity Pharmaceutical Holdings LLC (South San Francisco, Calif.) -- a holding company funded by CMEA Capital -- and Remeditex...

Read the full 222 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >